The Cloning and Mutagenesis Market should see a stand-out year in 2020 | Fortune Business Insights™

Posted on Jan 17 2020 11:09 AM

"The Cloning and Mutagenesis Market report provides detailed information regarding various insights of the industry. Some of them are growth drivers, hindrances, competitive landscape, regional analysis, and challenges. "

Growing number of people being affected by chronic diseases is likely to be the key driver in the global cloning and mutagenesis market growth. The World Health Organization estimates that by 2020, the prevalence of chronic diseases will rise by 57%. The primary reason for this staggering figure is the increasingly sedentary lifestyle being adopted by people in urban areas. Adding to this are factors such as unhealthy food habits, smoking and drinking, and lack of exercise. As a result, chronic diseases such as obesity and diabetes are on the rise globally. For example, WHO statistics reveal that there were 650 million obese adults (18 years and older) in 2016. These factors will favor the expansion of the global cloning and mutagenesis market size during the forecast period.

The report covers:

  • Global Cloning & Mutagenesis Market trends, with detailed analysis on consumer trends & manufacturer trends.
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe.
  • Competitive analysis of the industry players along with the overview on strategic management.
  • Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report:

Leading Players operating in the Cloning & Mutagenesis Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Agilent Technologies, Inc.
  • Genomax Technologies Pte Ltd.
  • Transgen Biotech Co., LTD
  • Thermo Fisher Scientific
  • EZBioscience
  • Jena Bioscience GmbH
  • New England Biolabs, abm Inc.
  • GENEWIZ Inc.
  • Takara Bio Inc.

Increasing Research Activities in Cancer and Other Rare Disorders to Fuel the Market

The global cloning and mutagenesis market is slated for substantial growth owing to the extensive and intensive research being undertaken to develop therapies for cancer and other rare disorders. For example, in 2017, clinical trials were conducted at the Royal Marsden Hospital in London on organoids. These are three-dimensional structures derived from the patient’s cancer cells and are expected to imitate a tumour’s response, representing a cloning technique. This can enable doctors to deliver more targeted and accurate treatment to cancer patients. Similarly, the International Rare Diseases Research Consortium (IRDiRC) has set itself a goal of developing 200 therapies by 2020 for different rare diseases. This bodes well for the global cloning and mutagenesis market revenue as public-funded research are getting a boost from bodies such as the European Commission and the Japan Agency for Medical Research and Development.

Global Cloning & Mutagenesis Market Segmentation

By Technique 

  • Blunt End Cloning
  • Topo PCR Cloning
  • Seamless Cloning
  • Site-Directed Mutagenesis
  • Others

By Product

  • Cloning Kits
  • Mutagenesis Kits

By End User

  • Academic & Research Institutes
  • Biotechnology Companies
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Have Any Query? Ask Our Experts:

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Cloning & Mutagenesis Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

Reasons to Purchase this Report:

  • Comprehensive analysis of the Cloning & Mutagenesis Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs